Artificial Intelligence in ALK -Rearranged NSCLC: Forecasting Response and Resistance.

Simple Summary: ALK-positive non-small-cell lung cancer is a distinct molecular subtype for which targeted therapies have significantly enhanced patient outcomes. However, prediction of treatment response and understanding of resistance mechanisms remain clinically challenging. Artificial intelligen...

Full description

Bibliographic Details

Published in:	Cancers Vol. 18; no. 6; pp. 973 - 989
Main Authors:	Koulouris, Andreas, Tsagkaris, Christos, Kalaitzidis, Konstantinos, Tsakonas, Georgios, Mountzios, Giannis
Format:	research systematic review tables/charts Journal Article
Published:	MDPI Mar2026
Online Access:	View this record in EBSCOhost